| Product# | Name | Image | CAS | Price |
|---|---|---|---|---|
| 10356 | Biotinoyl-2-Aminobutyric acid |  | $250.00 | |
| 10202 | NHS-dPEG®₄-biotinidase resistant biotin |  | $150.00 – $1,200.00 | |
| 10203 | TFP-dPEG®₄-biotinidase resistant biotin |  | $150.00 – $1,200.00 | |
| 10204 | TFP-dPEG®₁₂-biotinidase resistant biotin |  | $250.00 – $1,750.00 |
Biotinidase Resistant Biotin
Quanta BioDesign’s exclusive Biotinidase Resistant Biotin reagents create unique application opportunities for discerning scientists. Biotinidase is a ubiquitous mammalian enzyme that cleaves biotin from biocytin, making the free cofactor available to biotin-dependent enzymes such as carboxylases. However, biotinidase complicates applications such as antibody pretargeting with a biotin-streptavidin system because it attacks the targeting system’s biotin.
In 2006, D. Scott Wilbur, Donald K. Hamlin, and Ming-Kuan Chyan discovered a small biotin modification that resists biotinidase cleavage. Biotin binding to avidin or streptavidin remains unchanged. Our four amine-reactive Biotinidase Resistant Biotin products build on this discovery and enable new applications that expand the utility of the tight binding between biotin-avidin and biotin-streptavidin.
If your biotin-based application needs to evade biotinidase, try these products today and discover the dPEG® difference!